Treatment outcomes with tyrosine kinase inhibitors in patients with uncommon EGFR mutations in non-small cell lung cancer: A multi-centre retrospective analysis.Sarah Hunter, Eleni Karapanagiotou, Daniel Smith et al.|Journal of Clinical Oncology|2017Cited by 1
72: Treatment outcomes with tyrosine kinase inhibitors in patients with uncommon EGFR mutations in non-small cell lung cancerSarah Hunter, Eleni Karapanagiotou, Guillermina Nickless et al.|Lung Cancer|2017Cited by 0